Inicio Zine News ObsEva SA to Present New Clinical Data on its Lead Compounds Nolasiban...

ObsEva SA to Present New Clinical Data on its Lead Compounds Nolasiban and Linzagolix at the 75th Annual ASRM Meeting in Philadelphia, PA

21
0

Geneva, Switzerland and Boston, MA –October 9, 2019- ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss  clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced  the presentation of new data for its lead compounds, nolasiban and linzagolix, at the 75th American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo taking place in Philadelphia (PA) from October 12 -16, 2019.